According to a study published in Lancet, the optimal dose of low-molecular-weight heparin for venous thromboembolism ... Apixaban has been shown to be effective for preventing venous thromboembolism (VTE) in patients with cancer, but is ... Researchers from the Department of Medicine and the Ottawa Hospital Research Institute at the University of Ottawa in ... The Jansen Pharmaceutical Companies of Johnson & Johnson recently announced new data from the Phase III UNIVERSE ... Editor's Note: This article was co-authored by Dr. Sabah Skaf, a cardiologist and Assistant Director of Echocardiography ... Heart failure (HF) is an independent risk factor for venous thromboembolism (VTE), according to a study published in ... A new systematic review and meta-analysis indicates that there were no significant differences in venous thromboembolism ... Asymptomatic proximal deep vein thrombosis (DVT) is still useful as a clinically relevant endpoint, results from a new ... A new analysis suggests that in patients with SARS-CoV-2 (COVID-19), the risk for venous thromboembolism (VTE) remained ... Patients in the intensive care unit (ICU) for COVID-19 had high rates of major arterial or venous thromboembolism (VTE), ... Some Caucasian patients hospitalized with COVID-19 develop potentially deadly blood clotting in their lungs, according ...